No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
CN Stock MarketDetailed Quotes
300015 Aier Eye Hospital Group
- 10.35
- -0.43-3.99%
Market Closed Jul 23 15:00 CST
96.53BMarket Cap27.75P/E (TTM)
10.75High10.34Low727.94KlotVolume10.75Open10.78Pre Close766.49MTurnover0.92%Turnover Ratio28.75P/E (Static)9.33BShares20.6352wk High5.28P/B81.82BFloat Cap9.6752wk Low12.94Limit Up7.91BShs Float42.49Historical High8.62Limit Down3.80%Amplitude0.02Historical Low0.15Dividend TTM10.53Avg Price425.91KlotAsk1.45%Div YieldTTM100Lot Size284.66KlotBid
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Nomura Adjusts Aier Eye Hospital's Price Target to 13.70 Yuan From 15.35 Yuan, Keeps at Buy
As of December 31, 2023, Aier Eye Hospital Group had 256 hospitals and 183 outpatient departments in China.
On July 15th, Gelunhui reported that Aier Eye Hospital Group (300015.SZ) stated on the investor interaction platform that the company disclosed information in accordance with the relevant regulations of the exchange. As of December 31, 2023, the company has 256 domestic hospitals and 183 outpatient clinics. The medical institutions under the industry merger fund in which the company has participated have a total of 311.
Aier Eye Hospital Group Co., Ltd.'s (SZSE:300015) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Morgan Stanley Downgrades Aier Eye Hospital to Underweight From Equal-weight; Price Target Is 9.80 Yuan
Aier Eye Hospital Group (300015.SZ) has repurchased a total of 12.6587 million shares, with a total cost of 218 million yuan.
Aier Eye Hospital Group (300015.SZ) announced that as of June 30, 2024, the company repurchased 12.6587 million shares of the company through centralized bidding trading, accounting for 0.14% of the total share capital of the company. The total transaction amount was 218 million yuan (excluding transaction fees).
Private Companies Among Aier Eye Hospital Group Co., Ltd.'s (SZSE:300015) Largest Stockholders and Were Hit After Last Week's 3.9% Price Drop
Comments
Aier Eye Hospital Group could become a multi-bagger due to its high capital compounding rates. Despite higher stock prices, strong fundamentals warrant further research.
Why You Should Care About Aier Eye Hospital Group's (SZSE:300015) Strong Returns On Capital 1
Despite the recent decline in share price, long-term investors have seen a 15% return each year over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering.
Aier Eye Hospital Group's high P/E ratio, despite weaker growth predictions, pose risks for investors. The high P/E amidst lower growth forecasts suggest a potential for declining value in investments.
Aier Eye Hospital Group shows promising trends, hinting at potential multi-bagger status. High ROCE and continuous capital reinvestment suggest a bright future, but further research is advised due to strong performance.
The research is done by the respective broker and I do not endorse any of them. Just sharing here for information and reading pleasure.
UOBKH: Healthcare – China (Overweight) - Alpha Edge Investing
$WUXI BIO(02269.HK$ $WUXI APPTEC(02359.HK$ $INNOVENT BIO(01801.HK$ $VENUS MEDTECH-B(02500.HK$ $HENLIUS(02696.HK$ $Aier Eye Hospital Group(300015.SZ$ $Shenzhen Mindray Bio-Medical Electronics(300760.SZ$
UOBKH: Healthcare – China (Overweight) - Alpha Edge Investing
$WUXI BIO(02269.HK$ $WUXI APPTEC(02359.HK$ $INNOVENT BIO(01801.HK$ $VENUS MEDTECH-B(02500.HK$ $HENLIUS(02696.HK$ $Aier Eye Hospital Group(300015.SZ$ $Shenzhen Mindray Bio-Medical Electronics(300760.SZ$
Read more
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg